Brain Implant Being Studied at Jefferson Could Predict and Stop Epilepsy Seizures Before They Even BeginJuly 27, 2007An implanted stimulator being studied at Thomas Jefferson University Hospital may be able to predict and prevent seizures before they start in people with uncontrolled epilepsy. Researchers at the Jefferson Comprehensive Epilepsy Center are enrolling patients in a study of the Responsive Neurostimulator System (RNS) made by Neuropace to determine if it is effective in stemming seizures. The system contains a computer chip that detects seizures and then delivers electric current to the brain to stop them. "If it works as well as we hope, this device will be an exciting leap forward in the field," said Michael Sperling, M.D., director of the Jefferson Comprehensive Epilepsy Center and the Baldwin Keyes Professor of Neurology, Jefferson Medical College of Thomas Jefferson University. "This is the first closed-loop system being used in humans designed to stop seizures."
Earlier devices, such as a vagal nerve stimulator, gave out intermittent electrical stimulation to stop seizures, but never directly to the brain, explained Christopher Skidmore, M.D., principal investigator of the study at Jefferson. The RNS only delivers an electrical current when a seizure is detected and stimulation is needed. More than two million people in the U.S. have epilepsy, the third most common neurological disorder in the country. Approximately 30 to 40 percent of people with epilepsy have seizures that cannot be controlled with medications, leaving many unable to work or drive. Uncontrolled seizures related to epilepsy are generally treated with antiepileptic medications. However, many individuals treated with medication alone continue to experience seizures or medication side effects. Uncontrolled epilepsy can severely diminish quality of life and is often associated with increased rates of injury, depression, and death. Some people with severe epilepsy may be candidates for epilepsy surgery to remove the part of the brain that triggers the seizures, but this is not always feasible. The RNS system is an implantable device designed to detect abnormal electrical activity in the brain and deliver small amounts of electrical stimulation in response. It is placed by a surgeon within the skull and beneath the scalp. The device is then connected to two wires containing electrodes that are placed within the brain or resting on the brain surface in the area of the seizure focus. By continuously monitoring brain electrical activity, after identifying the "signature" of a seizure's onset, the device delivers brief electrical stimulations with the intention of suppressing the seizure before any symptoms occur. An early study of the RNS system in 65 adults with medically uncontrolled epilepsy indicated that the device was safe. As this is a controlled study, all study participants will receive the implant but only half of them will have the device activated in the initial phase. The others will have the device activated 16 weeks after surgery once the controlled phase is complete, said Dr. Sperling. "Patients who have the device activated one month after surgery will be monitored weekly at the epilepsy center to tweak the chip's programming for optimal performance," Dr. Skidmore said. Patients will also receive a device that is able to scan the chip for information about seizures just by holding a wand over the scalp, he said. The information can then be downloaded by the patient onto a computer and sent via telephone to epilepsy researchers to review. Participants in the RNS study must be from 18 to 70 years of age and meet the following requirements: * have disabling (significant enough to impair functional abilities or day-to-day life activities) motor simple partial seizures, complex partial seizures and/or secondarily generalized seizures; * failed treatment with a minimum of two antiepileptic medications; and * experienced an average of three or more disabling seizures every 28 days for three consecutive periods prior to enrollment and have no more than two regions that induce seizures in the brain. For more information or to participate in the study, please call 1-800-JEFF-NOW, 215-955-4672 or 1-866-904-6630 or visit http://www.jeffersonhospital.org or http://www.seizurestudy.com Thomas Jefferson University Hospital | |||||||||||||||||||||
|
Related Seizures Current Events and Seizures News Articles Direct recording shows brain signal persists even in dreamless sleep Neuroscientists at Washington University School of Medicine in St. Louis have taken one of the first direct looks at one of the human brain's most fundamental "foundations": a brain signal that never switches off and may support many cognitive functions. Pertussis: Adults can fall severely ill too Pertussis, also known as whooping cough, is not just a childhood disease. Indian spice reduces size of hemorrhagic stroke You might want to make curcumin part of your daily diet. This active ingredient of the Indian curry spice, turmeric, not only lowers your chances of getting cancer and Alzheimer's disease, but may reduce the size of a hemorrhagic stroke, say Medical College of Georgia researchers. Aberrations in region of chromosome 1q21.1 associated with broad range of disorders in children Researchers have discovered a submicroscopic aberration in a particular region of human chromosome 1q21.1 that appears to be associated with a variety of developmental disorders in children. 3T MRI leads to better diagnosis for focal epilepsy 3T MRI is better at detecting and characterizing structural brain abnormalities in patients with focal epilepsy than 1.5T MRI, leading to a better diagnosis and safer treatment of patients, according to a recent study conducted at the Oregon Health and Science University in Portland, OR. How memories are made, and recalled What makes a memory? Single cells in the brain, for one thing. For the first time, scientists at UCLA and the Weizmann Institute of Science in Israel have recorded individual brain cells in the act of calling up a memory, thus revealing where in the brain a specific memory is stored, and how it is able to recreate it. The first autism disease genes The autistic disorder was first described, more than sixty years ago, by Dr. Leo Kanner of the Johns Hopkins Hospital (USA), who created the new label 'early infantile autism'. Common treatment to delay labor decreases preterm infants' risk for cerebral palsy Intravenous magnesium sulfate supplementation before preterm delivery cuts the risk for handicapping cerebral palsy in half, according to research led by University of Alabama at Birmingham (UAB) obstetrician Dwight Rouse, M.D., and published in the Aug. 28 issue of The New England Journal of Medicine. High cholesterol levels drop naturally in children on high-fat anti-seizure diet, Hopkins study show Elevated cholesterol levels return to normal or near normal levels over time in four out of 10 children with uncontrollable epilepsy treated with the high-fat ketogenic diet, according to results of a Johns Hopkins Children's Center study reported in the Journal of Child Neurology. UC Davis researchers define characteristics, treatment options for XXYY syndrome Researchers at the UC Davis M.I.N.D. Institute and The Children's Hospital in Denver have conducted the largest study to date describing the medical and psychological characteristics of a rare genetic disorder in which males have two "X" and two "Y" chromosomes, rather than the normal one of each. More Seizures Current Events and Seizures News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||